The Lymphoma Hub uses cookies on this website. They help us give you the best online experience. By continuing to use our website without changing your cookie settings, you agree to our use of cookies in accordance with our updated Cookie Policy

Steering Committee About Us Newsletter Contact

Visit:

Steering Committee About Us Newsletter Contact

Subtypes Therapeutics Congresses Trials Expert Opinions

SOHO 2020

Lymphoma & CLL Subtypes

Assoc. Prof. Constantine Tam | ICML 2017 | Ibrutinib + venetoclax in R/R MCL

Anne Villeneuve

Constantine Tam

Jun 22, 2017

Ibrutinib + venetoclax in R/R MCL

More about...

Anne Villeneuve Constantine Tam Ibrutinib ICML 2017 Mantle cell lymphoma Mantle cell lymphomas Venetoclax

Related articles

EHA 2018 | Venetoclax monotherapy in patients with R/R MCL

EHA 2018 | Venetoclax monotherapy in patients with R/R MCL

Jul 26, 2018

EHA 2018 | Venetoclax monotherapy in patients with R/R MCL

EHA 2018 | Venetoclax monotherapy in patients with R/R MCL

Jul 26, 2018

Martin Dreyling | EHA 2018 | Overview of EHA presentations in indolent lymphoma

Martin Dreyling | EHA 2018 | Overview of EHA presentations in indolent lymphoma

Jun 18, 2018

Martin Dreyling | EHA 2018 | Overview of EHA presentations in indolent lymphoma

Martin Dreyling | EHA 2018 | Overview of EHA presentations in indolent lymphoma

Jun 18, 2018

Newsletter

Subscribe to get the best content related to lymphoma & CLL delivered to your inbox every month

First Name

Last Name

Email

I agree to the Lymphoma Hub Terms & Conditions